Tag: as

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Stellantis (STLA) To Contact Him Directly To Discuss Their Options

HOUSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Talen Energy Corporation (“Talen,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, today announced that it has received the remaining outstanding regulatory approvals related to its previously announced acquisition of the Lawrenceburg Power Plant (“Lawrenceburg”) in Indiana and the Waterford Energy Center (“Waterford”) and Darby Generating Station (“Darby”) in Ohio from Energy Capital Partners (“ECP”) (the “Acquisition”).

All amounts in Canadian dollars unless otherwise stated.

TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon” or the “Corporation”) announced today that the nominees listed in the Management Information Circular dated April 29, 2026 were elected as Directors of Aecon, to hold office until the close of the next Annual General Meeting of the Corporation or until their successors are appointed. 

CALGARY, Alberta, June 01, 2026 (GLOBE NEWSWIRE) -- PrairieSky Royalty Ltd. ("PrairieSky" or the "Company") (TSX: PSK) is pleased to announce that the Toronto Stock Exchange (the "TSX") has accepted the notice of PrairieSky's intention to commence a normal course issuer bid (the "NCIB").

All dollar amounts reflected in Canadian dollars unless otherwise stated.

Not for distribution to U.S. newswire services nor for dissemination to the United States
All amounts in Canadian dollars

BOSTON, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on June 1, 2026, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 61,050 shares of Vor Bio’s common stock and restricted stock units (“RSUs”) representing the right to receive an aggregate of 12,900 shares of Vor Bio’s common stock to 10 newly hired employees. The foregoing stock options and RSUs were granted as material inducements to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”).